Results 261 to 270 of about 3,223,608 (377)

HPA-axis hyperactivity and mortality in psychotic depressive disorder: Preliminary findings

open access: green, 2008
William Coryell   +3 more
openalex   +1 more source

C‐Reactive Protein and Neutrophil‐To‐Lymphocyte Ratio: Can They Be Used Interchangeably in Tracking Clozapine‐Related Inflammation?

open access: yesPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, EarlyView.
ABSTRACT Background Clozapine initiation often triggers inflammatory responses that can alter metabolism via Cytochrome P450 1A2 (CYP1A2) suppression. Although C‐reactive protein (CRP) is the recommended marker, it may be unavailable in community settings.
Nicoline Bihelek   +3 more
wiley   +1 more source

Cognitive burden of anticholinergic medications in psychotic disorders

open access: yesSchizophrenia Research, 2017
Seenae Eum   +14 more
semanticscholar   +1 more source

Validation of the German Version of the Movement Disorder Society Non‐Motor Scale (MDS‐NMS)

open access: yes
Movement Disorders Clinical Practice, EarlyView.
Jonas Bendig   +20 more
wiley   +1 more source

Considerations of race and ethnicity within rehabilitation studies for post COVID‐19 condition: A scoping review

open access: yesPM&R, EarlyView.
Abstract Post COVID‐19 condition (PCC) or long COVID disproportionately affects racial and ethnic minority communities. There are a growing number of rehabilitation studies for PCC, however, it has yet to be determined whether existing studies take race and ethnicity into account in their study designs and whether existing rehabilitative approaches are
Nadine Akbar   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy